The Potential of Ibrutinib Combinations for the Treatment of CLL

June 16, 2017
Javier Pinilla-Ibarz, MD, PhD

Javier Pinilla-Ibarz, MD, PhD, associate member, Malignant Hematology and Immunology Program at the H. Lee Moffitt Cancer Center, discusses ongoing research with ibrutinib (Imbruvica) in chronic lymphocytic leukemia.